BACKGROUND: We employed a cocaine intravenous self-administration model based on positive reinforcement of animals' instrumental reactions (i.e., lever pressing) rewarded by a dose of the drug. We also carried out simultaneous characterization of the pharmacokinetics of cocaine and its metabolites in rats during withdrawal; in this part of the experiments, we investigated the cocaine (2 mg/kg, iv)-induced changes in the distribution, rate constant, clearance and t₁/₂ of the parent drug and its metabolites in different structures of the brain and in peripheral tissues. METHODS: By using liquid chromatography-tandem mass spectrometry (LC/MS/MS) we measured the levels of cocaine and its major metabolites. RESULTS: Our results demonstrate differences in the levels of cocaine after cocaine self-administration in the rat, with the highest concentration seen in the striatum and the lowest in the cerebellum. Cocaine metabolites determined in the rat brain remained at very low levels (benzoylecgonine), irrespectively of the brain area, whereas the norcocaine concentration varied from 1.56 μg/g (the nucleus accumbens) to 2.73 μg/g (the striatum). CONCLUSION: A tandem LC/MS/MS is a valid method for evaluation of brain and peripheral levels of cocaine and its metabolites. Our results demonstrate brain area-dependent differences in the levels of cocaine after its self-administration in the rat. There were also differences in pharmacokinetic parameters among the brain areas and peripheral tissues following a bolus iv injection of cocaine to rats withdrawn from cocaine; among brain structures the slowest metabolic rate was detected for the striatum.
BACKGROUND: We employed a cocaine intravenous self-administration model based on positive reinforcement of animals' instrumental reactions (i.e., lever pressing) rewarded by a dose of the drug. We also carried out simultaneous characterization of the pharmacokinetics of cocaine and its metabolites in rats during withdrawal; in this part of the experiments, we investigated the cocaine (2 mg/kg, iv)-induced changes in the distribution, rate constant, clearance and t₁/₂ of the parent drug and its metabolites in different structures of the brain and in peripheral tissues. METHODS: By using liquid chromatography-tandem mass spectrometry (LC/MS/MS) we measured the levels of cocaine and its major metabolites. RESULTS: Our results demonstrate differences in the levels of cocaine after cocaine self-administration in the rat, with the highest concentration seen in the striatum and the lowest in the cerebellum. Cocaine metabolites determined in the rat brain remained at very low levels (benzoylecgonine), irrespectively of the brain area, whereas the norcocaine concentration varied from 1.56 μg/g (the nucleus accumbens) to 2.73 μg/g (the striatum). CONCLUSION: A tandem LC/MS/MS is a valid method for evaluation of brain and peripheral levels of cocaine and its metabolites. Our results demonstrate brain area-dependent differences in the levels of cocaine after its self-administration in the rat. There were also differences in pharmacokinetic parameters among the brain areas and peripheral tissues following a bolus iv injection of cocaine to rats withdrawn from cocaine; among brain structures the slowest metabolic rate was detected for the striatum.
Authors: I Mitch Taylor; Zhanhong Du; Emma T Bigelow; James R Eles; Anthony R Horner; Kasey A Catt; Stephen G Weber; Brian G Jamieson; X Tracy Cui Journal: J Mater Chem B Date: 2017-03-06 Impact factor: 6.331
Authors: Mauro Federici; Emanuele Claudio Latagliata; Ada Ledonne; Francesca R Rizzo; Marco Feligioni; Dave Sulzer; Matthew Dunn; Dalibor Sames; Howard Gu; Robert Nisticò; Stefano Puglisi-Allegra; Nicola B Mercuri Journal: J Biol Chem Date: 2013-11-26 Impact factor: 5.157
Authors: Mingming Yu; Hazem E Hassan; Ahmed Ibrahim; Kenneth S Bauer; Deanna L Kelly; Jia Bei Wang Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2014-06-20 Impact factor: 3.205
Authors: Emiliano J Sanchez; Robert P Hayes; John T Barr; Kevin M Lewis; Brian N Webb; Arun K Subramanian; Mark S Nissen; Jeffrey P Jones; Eric A Shelden; Barbara A Sorg; Michael Fill; James O Schenk; Chulhee Kang Journal: Drug Alcohol Depend Date: 2013-07-19 Impact factor: 4.492
Authors: Jessica M Illenberger; Steven B Harrod; Charles F Mactutus; Kristen A McLaurin; Asha Kallianpur; Rosemarie M Booze Journal: J Neuroimmune Pharmacol Date: 2020-06-12 Impact factor: 4.147
Authors: Martin J Hicks; Stephen M Kaminsky; Bishnu P De; Jonathan B Rosenberg; Suzette M Evans; Richard W Foltin; David M Andrenyak; David E Moody; George F Koob; Kim D Janda; Rodolfo J Ricart Arbona; Michelle L Lepherd; Ronald G Crystal Journal: Hum Gene Ther Clin Dev Date: 2014-03 Impact factor: 5.032
Authors: Ashley L St John; Hae Woong Choi; Q David Walker; Bruce Blough; Cynthia M Kuhn; Soman N Abraham; Herman F Staats Journal: NPJ Vaccines Date: 2020-02-05 Impact factor: 7.344